Clever-1/PD-L1 ratio predicts response to Bexmarilimab, a novel macrophage-guided immunotherapy, in immune deprived cancers Mari L. Bjorkman, Elisa M. Vuorinen,Juho Jalkanen, Marie-Louise Fjallskog,Jussi Koivunen, Teppo Huttunen,Maija Hollmen,Petri BonoCANCER RESEARCH（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
